This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
This week, we will discuss post-trial follow-up for EMPA-Kidney. What are the longer-term effects of empagliflozin for patients with chronic kidney disease?
Nausea is a very common and distressing problem. Some medications that treat nausea carry a higher risk for arrhythmias, like Torsades de Pointes, and sudden cardiac death. Is ondansetron safe for use in patients on hemodialysis?
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
We will be discussing a systematic review on treatment options for uremic pruritis. Such a simple symptom can be so bothersome, and is so common. Join us as we discuss the options on Sep 27
The chats were quite something. We sprinted through a lot of tweets in one hour each. Authors Chirag Parikh and Sherry Mansour joined us for first chat, and Sherry returned for the second chat too! Storifies below curated by Hector and Ben.
Could running marathons be hard on your kidneys, or at least biomarkers that track kidney injury> this paper in AJKD seems to suggest so. Join us to discuss this intriguing data and whether it should impact on runners, on May 23 and 24th.
One of the central problems with transplant is making sure patients take their anti-rejection medications. Reese et al. trialed a smart pill bottle that reminds patients to take their Program and snitches if they don't.